(Press-News.org) Highlights
Children with a particular kidney immune disorder that is unresponsive to standard treatments do not benefit from the immune drug rituximab.
Additional studies are needed to fully understand the disease and to develop effective therapies for hard-to-treat cases.
Washington, DC (May 10, 2012) — The drug rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis, has recently emerged as a potential treatment for a childhood kidney disorder known as idiopathic nephrotic syndrome (INS). While the cause of INS is not fully known, it is believed to be an immune disorder. Unfortunately, rituximab does not appear to benefit children who have INS that is resistant to standard treatments, according to a study appearing in an upcoming issue of new study in the Journal of the American Society of Nephrology (JASN).
INS has an estimated incidence of two to seven cases per 100,000 children and a prevalence of nearly 16 cases per 100,000. Children with the disease excrete large amounts of protein in their urine and exhibit other signs of kidney damage. Gian Marco Ghiggeri, MD (IRCCS Giannina Gaslini Children Hospital, in Genoa, Italy) and his colleagues recently reported that rituximab can successfully lower protein excretion in children with INS that responds to standard treatments consisting of steroids and immunosuppressants called calcineurin inhibitors. Therefore, rituxmab may allow such patients to discontinue these potentially toxic medications.
A few anecdotal cases and small studies also suggest that rituximab may benefit children with INS that is unresponsive to standard treatments. To test this more rigorously, Ghiggeri and his team conducted the first randomized controlled trial of rituximab in 31 children with INS that did not respond to steroids and calcineurin inhibitors. All children in the study continued taking steroids and calcineurin inhibitors at the doses they took before they enrolled. Half of the patients also received two doses of rituximab.
After three months of treatment, rituximab did not reduce protein excretion in the urine.
By identifying which patients benefit from rituximab and which do not, "our work represents a step forward on the road to treating nephrotic syndrome in children," said Dr. Ghiggeri. However, the negative results of this latest study suggest that researchers and clinicians need a much better understanding of INS to develop effective therapies against cases that are resistant to standard treatment.
INFORMATION:
Study co-authors include Alberto Magnasco, Corrado Murtas (IRCCS Giannina Gaslini Children Hospital, in Genoa, Italy); Pietro Ravani (University of Calgary, in Alberta, Canada); Alberto Edefonti, Luciana Ghio, Mirco Belingheri, (Ospedale Maggiore Policlinico, in Milan, Italy); Luisa Murer, Elisa Benetti (Azienda Ospedaliera-University of Padova, in Padova, Italy); Giovanni Messina (Ospedale Giovanni XXIII, in Bari, Italy); Laura Massella (IRCCS Bambin Gesù Children Hospital, in Rome, Italy); Maria Gabriella Porcellini (Regina Margherita Children Hospital, in Turin, Italy); Michela Montagna, Mario Regazzi (Foundation IRCCS Policlinico San Matteo, in Pavia, Italy); and Francesco Scolari (Ospedale di Montichiari, in Brescia, Italy).
Disclosures: The study was supported by the Renal Child Foundation (Genoa, Italy) and La Fondazione La Nuova Speranza (Milan, Italy).
The article, entitled "Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome," will appear online at http://jasn.asnjournals.org/ on May 10, 2012, doi: 10.1681/ASN.2011080775.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
END
Researchers at the Hofstra North Shore-LIJ School of Medicine and Feinstein Institute for Medical Research conducted a retrospective analysis which found that morbid obesity impedes kidney donation. In fact, in the analysis of 104 potential living kidney donors, 23 (22 percent) donors were classified as morbidly obese, only three (13 percent) of whom were able to successfully lose weight and donate their kidney. This data will be presented at the National Kidney Foundation (NKF) 2012 Spring Clinical Meetings, to be held from May 9-13 in Washington, DC.
Morbidly obese ...
People don't always do as their neighbors do, and the same is true of neighboring chimpanzees. That's according to a report published online on May 10 in the Cell Press journal Current Biology featuring observations of wild chimps as they used hammers to crack nuts.
"In humans, cultural differences are an essential part of what distinguishes neighboring groups that live in very similar environments," said Lydia Luncz of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany. "For the first time, a very similar situation has been found in wild chimpanzees ...
Social jetlag—a syndrome related to the mismatch between the body's internal clock and the realities of our daily schedules—does more than make us sleepy. It is also contributing to the growing tide of obesity, according to a large-scale epidemiological study reported online on May 10 in Current Biology, a Cell Press publication.
"We have identified a syndrome in modern society that has not been recognized until recently," said Till Roenneberg of the University of Munich. "It concerns an increasing discrepancy between the daily timing of the physiological clock and the ...
Heart attack patients in North Carolina who were rushed directly to hospitals equipped to do percutaneous coronary intervention (PCI) received treatment significantly faster than patients first taken to hospitals unequipped to perform PCI and then later transferred for treatment, according to research reported at the American Heart Association's Quality of Care and Outcomes Research 2012 Scientific Sessions.
The study focused on the most serious form of heart attack, ST-elevation myocardial infarction (STEMI). A STEMI typically involves complete blockage of the blood ...
Dr. Dale Hall, Oklahoma City podiatrist, is happy to be able to offer new patient services on his practice's website. He hopes the information for new patients makes it easier for patients to find the Oklahoma City, OK podiatrist and schedule appointments.
Dr. Hall's website features downloadable new patient forms that can be printed and filled out prior to coming in for the first appointment. This is designed to save time and expedite the process of coming in for a patient's first appointment. Instead of spending a large amount of time filling out forms, new patients ...
WASHINGTON—A vast city built by the ancient Maya and discovered nearly a century ago is finally starting to yield its secrets.
Excavating for the first time in the sprawling complex of Xultún in Guatemala’s Petén region, archaeologists have uncovered a structure that contains what appears to be a work space for the town’s scribe, its walls adorned with unique paintings — one depicting a lineup of men in black uniforms — and hundreds of scrawled numbers. Many are calculations relating to the Maya calendar.
One wall of the structure, thought to be a house, is covered with ...
Carl J. Taylor & Co., a Texas executive search firm based in Dallas, is receiving an increase in inquiries from employers who are unable to find the people they need for middle and senior level executive positions. According to Carl Taylor, President of the firm, the inquiries are coming from a wide variety of businesses.
"We have had a number of contacts from some very small companies," said Taylor. "Some of these smaller organizations are start-ups or relatively new companies, but many of them have been in business for several years." Taylor ...
Patients receiving telemonitoring along with high blood pressure management support from a pharmacist were more likely to lower their blood pressure than those not receiving extra support, according to research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2012.
"Patients with high blood pressure visit physicians an average of four times each year, yet blood pressure is controlled in only about half of U.S. patients," said Karen Margolis, M.D., M.P.H., the study's lead author and director of clinical research of ...
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2012.
"Although it's the only drug approved by the Food and Drug Administration to treat acute ischemic stroke, tPA is underused among patients on home warfarin therapy mainly because of the fear that it will cause bleeding," said Ying Xian, M.D., Ph.D., the study's lead author and a research fellow ...
Cincinnati, OH, May 10, 2012 – In 2009, children with public insurance were three times more likely and children with no insurance were eleven time more likely not to have a primary care physician, compared with children with private insurance. Without a primary care physician, the Emergency Department (ED) often becomes the primary point of contact for treatments and diagnoses. A new study scheduled for publication in The Journal of Pediatrics reports that children with private, public, and no insurance may receive differing levels of treatment in EDs.
Rebekah Mannix, ...
